Clin2
NCT00369421Possibly a fitRecruiting

Diagnosis and care for inherited metabolic conditions

Arterial Calcification Due to Deficiency of CD73

Part of Genetic & congenital, Hormones & metabolism clinical trials.

This trial helps evaluate people who may have an inherited (genetic) metabolic or related disorder, and sometimes includes treatment or guidance based on the diagnosis. It may involve blood and urine testing, and participation can include in-person visits or telehealth.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
4,000 people
Ages
1 month to 115 years
Study type
Observational

Who can take part

  • You are 1 month old or older, and your situation is known or suspected to be inherited/genetic (often affecting metabolism).
  • If you are older than 2 years, you must be medically stable (safe to travel/assess) for an NIH admission for diagnosis.
  • If you are 1 month to 2 years old (or under 12 kg), your case must be reviewed by the pediatric consult team before scheduling.
  • You must not be pregnant at the time of enrollment.
  • You may be asked to provide blood and urine samples for testing and comparison with family members/controls. (Normal adult volunteers may also provide samples.)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02089789Recruiting
Study of inherited glycosylation disorders for diagnosis

This study helps doctors diagnose congenital (from birth) glycosylation disorders, which are inherited conditions that affect how the body builds certain sugar-related proteins. You (or your child) may have clinic visits, blood or other samples, and possibly genetic testing—especially if there are family members with a known or suspected condition.

Bethesda, Maryland
NCT04602325Recruiting
Blood and brain injury biomarker study for inherited metabolic disorders

This trial studies blood and other measurable signs (biomarkers) that may reflect brain injury after certain inherited metabolic conditions. Results may help doctors better detect and understand brain effects from these illnesses, especially episodes that affect the brain.

Washington D.C., District of Columbia
NCT00078078Recruiting
Understanding Methylmalonic Acidemia and Cobalamin Disorders

This research study follows patients with methylmalonic acidemia (a rare metabolic disorder affecting how the body breaks down certain proteins) or cobalamin (vitamin B12) disorders to better understand how these conditions develop and progress over time. Researchers will collect medical information, blood samples, and eye exams to help improve future treatments.

Washington D.C., District of Columbia
NCT01143454Recruiting
Study unusual heart conditions and related genetic traits

This study looks at people with unusual or rare heart problems, or people with a family history of these issues. Doctors and researchers may collect and study your blood or tissue (and possibly store samples) to learn what causes the condition and how it may affect the heart.

Washington D.C., District of Columbia
NCT01780168Recruiting
Study of metabolism, infection, and immunity in mitochondrial disease

This study looks at how metabolism, infections, and the immune system work together in people with mitochondrial disease. It aims to learn more about the condition and may help guide future treatments.

Bethesda, Maryland
NCT06092346Recruiting
Understanding rare purine and pyrimidine metabolism disorders

This study aims to learn more about rare disorders of purine and pyrimidine metabolism (DPPM), which can affect the brain, immune system, kidneys, and muscles. Researchers will study people with these disorders, their family members, and healthy volunteers to better understand the condition over time.

Bethesda, Maryland

Hear when a new Arterial Calcification Due to Deficiency of CD73 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.